AzTrials
AzTrials

Quality of LifeNCT04892628

Effects of Progressive Resistance Training Compared With Aerobic Training in Patients With Hemophilia

A study testing Progressive resistance training and Aerobic training in people with Quality of Life and Muscle Weakness, run by Dow University of Health Sciences at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to assess the effects of progressive resistance training compared with aerobic training, among those with hemophilia. Participants will be divided into two groups. The control group will receive an aerobic exercise protocol, and the resistance group will follow a resistance training program. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Quality of Life, Muscle Weakness
What is being tested?
Progressive resistance training and Aerobic training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
3 Apr 2021to 30 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • clinically diagnosed with hemophilia A or B (mild to moderate hemophilia (mild hemophilia - 0.05-0.4 IU, moderate hemophilia - 0.01-0.05 IU)
  • undergo pre- and post-program objective assessment of manual muscle testing and Hemophilia Joint Health Score, as well as subjective assessment of and Rating of Perceived Exertion.
  • willing to train two times a week
  • males and females between 18 to 45 years of age.
  • those who can ambulate without assistance

Who cannot join

  • unable to attend exercise sessions for the complete duration of the study
  • those who have had surgery performed 6 weeks before, or in duration of training (due to any disability)
  • involvement in any other training, or rehabilitation, during study
  • change in medicine within the study
  • history of major bleeding episodes that could pose a risk
  • history of factor 8 or factor 9 inhibitor

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Hemophilia welfare society karachi

    Karachi, Sindh

Other trials in Pakistan

About this study

Official title: Measurement of Subjective and Objective Indices After Progressive Resistance Training Compared With Aerobic Training in Patients With Hemophilia: a Randomised Controlled Trial

This study aims to assess the effects of progressive resistance training compared with aerobic training, among those with hemophilia. Participants will be divided into two groups. The control group will receive an aerobic exercise protocol, and the resistance group will follow a resistance training program. Each group will receive a total of eight sessions. Target muscles are deltoids, biceps, triceps, quadriceps, hamstrings, and calves.

Subjective and objective assessment will be performed for each group, to determine the effectiveness of each intervention.

Read the detailed description

Participant's height, weight and age will be recorded for pre-test anthropometric data. Height will be measured using a stadiometer, and weight will be measured with an electronic scale.

Treatment sessions will be conducted twice a week, for 8 weeks. The control group will be administered a standard physical therapy intervention program which will consist of active muscle stretching and aerobic exercises.

Exercises will include:

  • Flexion, extension and abduction at the shoulder joint for anterior, middle and posterior fibers of deltoid
  • Flexion and extension at the elbow for biceps and triceps trachii
  • Flexion and extension at the knee joint for quadriceps and hamstring muscles
  • Plantar flexion at the ankle joint for gastrocnemius and soleus Three sets of ten repetitions of each exercise will be done.

The intervention group will undergo a progressive resistance training program consisting of active muscle stretching and resistance training. Exercise for intervention group will consist of:

  • Resisted flexion, extension and abduction at the shoulder joint for anterior, middle and posterior deltoid, using dumbbells
  • Resisted flexion and extension at the elbow for biceps and triceps trachii, using dumbbells
  • Resisted flexion and extension of knee joint for quadriceps and hamstring muscles, using therabands
  • Resisted dorsiflexion and plantar flexion of gastrocnemius and soleus, using therabands

Resistance will be increased on basis of progressive overload principle. Three sets of ten repetitions will be performed per muscle group. Initial weight of the dumbbells will be 1kg and will be increased by 0.5kg per week. Therabands used will be Yellow, Red, Green and Blue. Resistance for therabands will be upgraded every two weeks. Treatment time per group will be approximately 40 minutes. Exercises will be progressed in a gradual manner to give participants time to build muscle strength.

Being tested
Progressive resistance training, Aerobic training
Keywords
Hemophilia, resistance training, aerobic exercise, Pakistan
Medical subject headings
Muscle Weakness, Hemophilia A

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Progressive resistance trainingOther

    Resistance training of upper limb and lower limb muscles. Resistance will be increased on a weekly basis. Dumbbells and therabands will be used to provide resistance.

  • Aerobic trainingOther

    The control group will be administered a standard physical therapy intervention program which will consist of active muscle stretching and aerobic exercises.

Study groups in NCT04892628
Study groupRoleWhat they receive
Aerobic training groupOtherThe control group will be administered a standard physical therapy intervention program which will consist of active muscle stretching and aerobic exercises. Exercises will include: * Flexion, extension and abduction at the shoulder joint for anterior, middle and posterior fibers of deltoid * Flexion and extension at the elbow for biceps and triceps trachii * Flexion and extension at the knee joint for quadriceps and hamstring muscles * Plantar flexion at the ankle joint for gastrocnemius and soleus Three sets of ten repetitions of each exercise will be done.
Receives: Other: Aerobic training
Resistance training groupExperimentalThe intervention group will undergo a progressive resistance training program consisting of active muscle stretching and resistance training. Exercise for intervention group will consist of: * Resisted flexion, extension and abduction at the shoulder joint for anterior, middle and posterior deltoid, using dumbbells * Resisted flexion and extension at the elbow for biceps and triceps trachii, using dumbbells * Resisted flexion and extension of knee joint for quadriceps and hamstring muscles, using therabands * Resisted dorsiflexion and plantar flexion of gastrocnemius and soleus, using therabands Resistance will be increased on basis of progressive overload principle. Three sets of ten repetitions will be performed per muscle group. Initial weight of the dumbbells will be 1kg and will be increased by 0.5kg per week.
Receives: Other: Progressive resistance training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Manual Muscle Testing - Daniel & Worthingham's

    An objective marker to determine muscle strength. It ranges from 0-5

    0 no movement of muscle

    1. flickering movement of muscle
    2. full range of motion in a gravity minimized position
    3. full range of motion against gravity, without resistance
    4. muscle can hold against moderate resistance
    5. muscle can hold against maximal resistance

    Measured: baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

  2. Hemophilia Joint Health Score (HJHS v2.1)

    The HJHS measures joint health, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia: the knees, ankles, and elbows. It can be used when there is a need for orthopedic intervention, or as an outcome measure of physiotherapy interventions.

    A scoring system is present, which combines the score of these questions, with a global gait score, to give an overall score. The greater the score, the poorer the outcome.

    The HJHS 2.1 provides a total score (higher score is worse; max=124), joint specific scores, and a global gait score.

    Measured: baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

  3. Borg Rating of Perceived Exertion

    The second subjective marker. This will be used to assess the subjective workload of exercises, and to note if exercise intensity decreases over time.

    The values range from 6-20, with 6 rated as 'no exertion', and 20 rated as 'maximal exertion'.

    Measured: baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

  4. HEP-Test-Q (Hemophilia and Exercise Project)

    The subjective marker of this study. This measure will assess the quality of life. It is a scale specifically designed for people with hemophilia.

    The HEP-Test-Q consists of 25 items pertaining to 4 domains 'mobility', 'strength \& coordination', 'endurance' and 'body perception' and one single item, which assesses changes in physical functioning in comparison to the previous year.

    The recall period for the assessment of physical functioning is over "the past four weeks".

    The response options range on a 5-point Likert scale from "never" to "always".

    Some of the items have to be re-coded. Subscales and the total score are transformed to a scale of 0-100 with high scores indicating better physical functioning.

    Measured: baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2021
  2. Study start3 Apr 2021
  3. Primary completion30 Sep 2021
  4. Study completion30 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04892628
Sponsor's protocol ID
Hem_resistance_aerobic_pk
Status last verified
Mar 2022
First submitted
4 May 2021
Last updated
23 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Parhampour B, Dadgoo M, Vasaghi-Gharamaleki B, Torkaman G, Ravanbod R, Mirzaii-Dizgah I, Reza Baghaipour M, Saneii SH. The effects of six-week resistance, aerobic and combined exercises on the pro-inflammatory and anti-inflammatory markers in overweight patients with moderate haemophilia A: A randomized controlled trial. Haemophilia. 2019 Jul;25(4):e257-e266. doi: 10.1111/hae.13764. Epub 2019 May 26.

    PubMed 31131517

Questions about this trial

What is this clinical trial studying?

A study testing Progressive resistance training and Aerobic training in people with Quality of Life and Muscle Weakness, run by Dow University of Health Sciences at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Manual Muscle Testing - Daniel & Worthingham's (time frame: baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04892628, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in